Na, B.; Kang, C.H.; Yun, T.; Park, J.H.; Na, K.J.; Park, S.; Lee, H.J.; Park, I.K.; Kim, Y.T.; Keam, B.;
et al. Neoadjuvant Concurrent Chemoradiotherapy Versus Neoadjuvant Chemotherapy in Thymic Epithelial Tumors: A Propensity Score-Matched Analysis. Cancers 2026, 18, 85.
https://doi.org/10.3390/cancers18010085
AMA Style
Na B, Kang CH, Yun T, Park JH, Na KJ, Park S, Lee HJ, Park IK, Kim YT, Keam B,
et al. Neoadjuvant Concurrent Chemoradiotherapy Versus Neoadjuvant Chemotherapy in Thymic Epithelial Tumors: A Propensity Score-Matched Analysis. Cancers. 2026; 18(1):85.
https://doi.org/10.3390/cancers18010085
Chicago/Turabian Style
Na, Bubse, Chang Hyun Kang, Taeyoung Yun, Ji Hyeon Park, Kwon Joong Na, Samina Park, Hyun Joo Lee, In Kyu Park, Young Tae Kim, Bhumsuk Keam,
and et al. 2026. "Neoadjuvant Concurrent Chemoradiotherapy Versus Neoadjuvant Chemotherapy in Thymic Epithelial Tumors: A Propensity Score-Matched Analysis" Cancers 18, no. 1: 85.
https://doi.org/10.3390/cancers18010085
APA Style
Na, B., Kang, C. H., Yun, T., Park, J. H., Na, K. J., Park, S., Lee, H. J., Park, I. K., Kim, Y. T., Keam, B., & Kim, H. J.
(2026). Neoadjuvant Concurrent Chemoradiotherapy Versus Neoadjuvant Chemotherapy in Thymic Epithelial Tumors: A Propensity Score-Matched Analysis. Cancers, 18(1), 85.
https://doi.org/10.3390/cancers18010085
